STEPHANIE VERGES: Open Payments
NPI 1821832916 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,768 in 67 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $435 · 2025 $1,768
Food & beverage: $1,583Education: $185
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $567 |
| Janssen Biotech, Inc. | 9 | $298 |
| GENZYME CORPORATION | 5 | $137 |
| Organon LLC | 2 | $130 |
| Novartis Pharmaceuticals Corporation | 4 | $112 |
| Incyte Corporation | 4 | $96 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $84 |
| Lilly USA, LLC | 3 | $75 |
| PFIZER INC. | 4 | $73 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, RINVOQ, VTAMA, OPZELURA, EBGLYSS, CIBINQO.
Industry payments across AL — which companies pay providers there.
